Medibio Limited (MEB.XA)

0.0010 0.0000 (0.00%) At close: 11:06AM AEST

Medibio Limited

100 Albert Road
Level 4 South Melbourne
Melbourne, VIC 3205
Australia
61 3 9692 7222
https://medibio.com.au

Sector(s): 
Industry: 
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Thomas R. Young M.D.	Chief Exec. Officer	N/A	N/A	N/A
Ms. Renee Stanton-Horne	Operations & Account Mang.	N/A	N/A	N/A
Ms. Stephanie Ottens	Investor Relations Director	N/A	N/A	N/A
Mr. Josh Purdy	PR Director	N/A	N/A	N/A
Dr. Michael Player	Head of Research	N/A	N/A	N/A
Dr. Matthew Flax	Head of Algorithm Devel. Team	N/A	N/A	N/A
Mr. Archie Defillo M.D.	Chief Medical Officer	N/A	N/A	N/A
Ms. Jennifer Solitario	Sr. VP of Corp. Health	N/A	N/A	N/A
Mr. Massimiliano Grassi	Head of Artificial Intelligence	N/A	N/A	N/A
Mr. Mathew Watkins C.A.	Company Sec.	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Medibio Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is headquartered in Melbourne, Australia.

Corporate governance

Medibio Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.